o(6)-benzylguanine has been researched along with Triple Negative Breast Neoplasms in 1 studies
O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoury, M | 1 |
| Bauerschlag, D | 1 |
| Zeppernick, F | 1 |
| von Felbert, V | 1 |
| Berges, N | 1 |
| Di Fiore, S | 1 |
| Mintert, I | 1 |
| Bleilevens, A | 1 |
| Maass, N | 1 |
| Bräutigam, K | 1 |
| Meinhold-Heerlein, I | 1 |
| Stickeler, E | 1 |
| Barth, S | 1 |
| Fischer, R | 1 |
| Hussain, AF | 1 |
1 other study available for o(6)-benzylguanine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
Topics: Cell Line, Tumor; Cell Survival; Chondroitin Sulfate Proteoglycans; Epithelial Cell Adhesion Molecul | 2016 |